{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:09:15Z","timestamp":1783523355149,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MO 2017\/4-1"],"award-info":[{"award-number":["MO 2017\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GR2305A"],"award-info":[{"award-number":["01GR2305A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013710","name":"European Federation of Immunological Societies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["91771964"],"award-info":[{"award-number":["91771964"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.placenta.2025.07.088","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:15:17Z","timestamp":1754424917000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Complement proteins, annexin V, and angiogenic markers in placental tissue of autoimmune disease patients"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-5228","authenticated-orcid":false,"given":"Aleida Susana","family":"Castellanos Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Fuentes-Zacarias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Ba\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Schleu\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Groten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-059X","authenticated-orcid":false,"given":"Diana Maria","family":"Morales-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.berh.2017.09.011","article-title":"Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","author":"Fischer-Betz","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.placenta.2025.07.088_bib2","first-page":"145","article-title":"Pregnancy and autoimmune disease","volume":"119","author":"Merz","year":"2022","journal-title":"Dtsch Arztebl Int."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.placenta.2025.07.088_bib4","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.placenta.2025.07.088_bib5","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci. Med."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.placenta.2025.07.088_bib8","series-title":"Kelley & Firestein's Textbook of Rheumatology","first-page":"355","article-title":"Effector mechanisms in autoimmunity and inflammation: complement system","author":"Trouw","year":"2017"},{"issue":"4","key":"10.1016\/j.placenta.2025.07.088_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2017-212224","article-title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and\/or antiphospholipid antibodies","volume":"77","author":"Kim","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12016-009-8183-5","article-title":"Complement activation and pregnancy failure","volume":"39","author":"Tincani","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/imr.13169","article-title":"Alternative pathway activation in pregnancy, a measured amount \"complements\" a successful pregnancy, too much results in adverse events","volume":"313","author":"Smith-Jackson","year":"2023","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00281-017-0645-x","article-title":"Complement activation, a threat to pregnancy","volume":"40","author":"Girardi","year":"2018","journal-title":"Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.placenta.2025.07.088_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.thromres.2009.11.033","article-title":"Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction","volume":"125","author":"Sifakis","year":"2010","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.placenta.2025.07.088_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2011.04.007","article-title":"Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases","volume":"10","author":"Iaccarino","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49768-w","article-title":"House\" assays for the quantification of Annexin V and its autoantibodies in patients with recurrent pregnancy loss and in vitro fertilisation failures","volume":"13","author":"Murad","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42358-020-00140-w","article-title":"Anti-annexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study","volume":"60","author":"Horimoto","year":"2020","journal-title":"Adv. Rheumatol."},{"issue":"7","key":"10.1016\/j.placenta.2025.07.088_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211026809","article-title":"Association between ANXA5 haplotypes and the risk of recurrent pregnancy loss","volume":"50","author":"Zheng","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.placenta.2025.07.088_bib19","series-title":"Annexins in Antiphospholipid Syndrome","author":"Rand","year":"2006"},{"issue":"4","key":"10.1016\/j.placenta.2025.07.088_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/antib9040067","article-title":"The role of complement in angiogenesis","volume":"9","author":"Markiewski","year":"2020","journal-title":"Antibodies"},{"issue":"4","key":"10.1016\/j.placenta.2025.07.088_bib21","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5292","article-title":"Predictive value of the sFlt-1\/PlGF ratio in women with suspected preeclampsia: an update","volume":"52","author":"Velegrakis","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.placenta.2025.07.088_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential role of complement in pregnancy: from implantation to parturition and beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.placenta.2025.07.088_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jri.2018.04.002","article-title":"Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus","volume":"127","author":"Mayer-Pickel","year":"2018","journal-title":"J. Reprod. Immunol."},{"issue":"9","key":"10.1016\/j.placenta.2025.07.088_bib25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.placenta.2025.07.088_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2025.07.088_bib27","article-title":"Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: diagnostic value added","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2025.07.088_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ijlh.14268","article-title":"Noncriteria antiphospholipid antibodies in antiphospholipid syndrome","volume":"46","author":"Devreese","year":"2024","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.placenta.2025.07.088_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.placenta.2023.06.013","article-title":"Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes","volume":"139","author":"Castellanos Gutierrez","year":"2023","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/rheumatology\/kez419","article-title":"Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry","volume":"59","author":"Alijotas-Reig","year":"2020","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.placenta.2025.07.088_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000357592","article-title":"Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol","volume":"36","author":"Figueras","year":"2014","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.placenta.2025.07.088_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.placenta.2025.07.088_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the pathophysiology of the antiphospholipid syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.placenta.2025.07.088_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2019.00885","article-title":"Opposite profiles of complement in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) among patients with antiphospholipid antibodies (aPL)","volume":"10","author":"Savelli","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.placenta.2025.07.088_bib36","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.placenta.2025.07.088_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1093526619836025","article-title":"Absence of distinct immunohistochemical distribution of annexin A5, C3b, C4d, and C5b-9 in placentas from patients with antiphospholipid antibodies, preeclampsia, and systemic lupus erythematosus","volume":"22","author":"Matrai","year":"2019","journal-title":"Pediatr. Dev. Pathol."},{"issue":"2","key":"10.1016\/j.placenta.2025.07.088_bib38","doi-asserted-by":"crossref","first-page":"167 e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib39","first-page":"175","article-title":"Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi","volume":"56","author":"Sinha","year":"1984","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.placenta.2025.07.088_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13185","article-title":"Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome","volume":"82","author":"Scambi","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2025.07.088_bib42","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fimmu.2018.01388","article-title":"Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.placenta.2025.07.088_bib43","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss","volume":"225","author":"Cohen","year":"2011","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.placenta.2025.07.088_bib44","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.placenta.2025.07.088_bib45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trre.2009.02.005","article-title":"3rd, mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.placenta.2025.07.088_bib47","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia?","volume":"10","author":"Pierik","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/pin.12041","article-title":"Complement split product C4d deposition in placenta in systemic lupus erythematosus and pregnancy-induced hypertension","volume":"63","author":"Minamiguchi","year":"2013","journal-title":"Pathol. Int."},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00428-015-1759-y","article-title":"Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage","volume":"466","author":"Kim","year":"2015","journal-title":"Virchows Arch."},{"key":"10.1016\/j.placenta.2025.07.088_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1160\/TH11-08-0554","article-title":"Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome","volume":"107","author":"Breen","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.placenta.2025.07.088_bib53","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40136","article-title":"Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: pathogenesis to translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib54","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0002-9378(94)90403-0","article-title":"Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion","volume":"171","author":"Rand","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.placenta.2025.07.088_bib55","doi-asserted-by":"crossref","first-page":"28418","DOI":"10.3390\/ijms161226104","article-title":"Thrombophilia and pregnancy complications","volume":"16","author":"Simcox","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.placenta.2025.07.088_bib56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/rth2.12107","article-title":"Integrating platelet and coagulation activation in fibrin clot formation","volume":"2","author":"Swieringa","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.placenta.2025.07.088_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk - factor H in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.placenta.2025.07.088_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.placenta.2025.07.088_bib59","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.placenta.2025.07.088_bib60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.placenta.2025.07.088_bib61","doi-asserted-by":"crossref","first-page":"108 e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2025.07.088_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.preghy.2018.01.008","article-title":"The role of angiogenic biomarkers and uterine artery doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome","volume":"11","author":"Rodriguez","year":"2018","journal-title":"Pregn. Hypertens"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425003297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425003297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:49:29Z","timestamp":1779857369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":62,"alternative-id":["S0143400425003297"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.07.088","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement proteins, annexin V, and angiogenic markers in placental tissue of autoimmune disease patients","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.07.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}